While guanosine supplementation in untreated LSCs did not affect the expression of myeloid differentiation markers CD11b and Gr-1, guanosine treatment of MMF-treated LSCs remarkably reversed myeloid differentiation (Fig. 3h), establishing that reduced guanine nucleotides promote myeloid differentiation of AML. Here, ITGAM is linked to acute myeloid leukemia.